{{Rsnum
|rsid=2338
|Chromosome=6
|position=1573378
|Orientation=plus
|GMAF=0.3329
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.4 | 46.0 | 49.6
| HCB | 6.6 | 40.1 | 53.3
| JPT | 3.5 | 39.8 | 56.6
| YRI | 8.2 | 28.6 | 63.3
| ASW | 5.3 | 42.1 | 52.6
| CHB | 6.6 | 40.1 | 53.3
| CHD | 9.2 | 41.3 | 49.5
| GIH | 14.9 | 41.6 | 43.6
| LWK | 15.5 | 46.4 | 38.2
| MEX | 31.0 | 51.7 | 17.2
| MKK | 8.3 | 48.7 | 42.9
| TSI | 11.8 | 38.2 | 50.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22020760
|Trait=None
|Title=Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients.
|RiskAllele=
|Pval=0.000005
|OR=2.2700
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}